Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS)
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2013
At a glance
- Drugs Mecasermin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 14 Feb 2013 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 10 Dec 2007 Status changed from in progress to completed.
- 09 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History